ISSN: 1838-7640Theranostics
Global reach, higher impact
Theranostics 2017; 7(8):2287-2288. doi:10.7150/thno.19286 This issue Cite
Commentary
Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis
1. Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China;
2. Department of Cardiovascular Surgery, West China Hospital of Sichuan University, Chengdu, China.
* These two authors contributed equally to this work.
Citation:
Chen Z, Li Y, Dian K, Rao L. Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis. Theranostics 2017; 7(8):2287-2288. doi:10.7150/thno.19286. https://www.thno.org/v07p2287.htm
Other stylesCommentary-article in Theranostics, Volume 6, 2068
Abstract
This commentary highlights the findings by Tao et al. (Theranostics 2016; 6: 2068-2083) that targeting miR-433 may be a potential therapeutic strategy for myocardial fibrosis and subsequently discusses the obstacles and prospects associated with the application of therapeutic microRNAs in anti-fibrosis treatment.
Keywords: Cardiac fibrosis, microRNAs, Therapeutic targets.
Citation styles
APA
Chen, Z., Li, Y., Dian, K., Rao, L. (2017). Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis. Theranostics, 7(8), 2287-2288. https://doi.org/10.7150/thno.19286.
ACS
Chen, Z.; Li, Y.; Dian, K.; Rao, L. Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis. Theranostics 2017, 7 (8), 2287-2288. DOI: 10.7150/thno.19286.
NLM
Chen Z, Li Y, Dian K, Rao L. Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis. Theranostics 2017; 7(8):2287-2288. doi:10.7150/thno.19286. https://www.thno.org/v07p2287.htm
CSE
Chen Z, Li Y, Dian K, Rao L. 2017. Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis. Theranostics. 7(8):2287-2288.
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.